Turn Therapeutics Inc. (TTRX) Financials

TTRX Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 18.6 million 12.5 million
Dec. 31, 2025 12.2 million 7.5 million
Sept. 30, 2025 4.4 million 3.8 million
June 30, 2025 4.3 million 2.6 million

TTRX Free Cash Flow and Stock based compensation

No data available :(

TTRX Net Income

No data available :(

TTRX Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 11.2 million 5.9 million 21539
Dec. 31, 2025 5.1 million - 80376
Sept. 30, 2025 3.1 million - 46344
June 30, 2025 3.2 million - 101446

TTRX Shares Outstanding

No data available :(

TTRX Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 3 109434 1.1 million -
Dec. 31, 2025 3 34934 2.1 million -
Sept. 30, 2025 - 158699 1.7 million -
June 30, 2025 4 62678 1.3 million -

TTRX Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 14451
Dec. 31, 2025 - 14155
Sept. 30, 2025 - 13679
June 30, 2025 - -

TTRX

Price: $6.27

52 week price:
2.57
26.50

Earnings Per Share: -0.13 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 171.1 million

Links: